Quantcast
Channel: contract manufacturing
Browsing latest articles
Browse All 41 View Live

Cytovance expands its biologics manufacturing and warehousing operations

With the the coming entry of biosimilars in the U.S. and expansion of that market in Europe, biologic drugs are going to be in greater demand, as will the contract manufacturers who can supply the cell...

View Article



Ben Venue Labs may be closed but it is still recalling products

A voluntary recall was issued Friday after there was a report of a single visible glass particle in a vial in a lot that was produced for Genco Pharmaceutical Services.read more

View Article

CMO born from $2.6 billion merger comes on the scene as DPx

A new company, initially dubbed NewCo and created by the $2.6 billion merger of contract manufacturer Patheon and Netherlands-based DSM Pharmaceutical Products, has officially broken onto the scene. It...

View Article

FDA sues to halt production of 'unapproved' vaginal gel products

California contract manufacturer Laclede was warned. Now it is being legally stormed. After years of letters, inspections and meetings with the FDA couldn't move the company to seek an NDA for its...

View Article

Global CMOs tipped to enter Russia as local drug production deadline nears

While geopolitical instability in Eastern Europe would appear to make Russia a risky bet, the size of the market and incoming targets on drug production mean the likes of Abbott Laboratories are still...

View Article


Aptuit putting $1M into cytotoxic capabilities in Scotland

Contract services company Aptuit will invest $1 million in its facility in Glasgow, Scotland, to expand its capacity to manufacture sterile cytotoxic liquid and lyophilized drug products.read more

View Article

Cubist issues third recall in 12 months after another CMO quality failing

Cubist is going through a bad patch with outsourced production. The problems began in August 2013, when CMO quality failings prompted Cubist to recall four lots of its injectable antibiotic Cubicin....

View Article

Grand River opens new finishing facility

Grand River Aseptic Manufacturing (GRAM), a small parenteral contract manufacturing company in Grand Rapids, MI, has opened a new 28,000-square-foot facility for its finishing operations, inspection...

View Article


Avid Bioservices doubling capacity at its California facility

California-based Peregrine Pharmaceuticals says that contract manufacturing revenue was off in its last quarter but demand remains high for its Avid Bioservices unit, and so like a number of contract...

View Article


India's Piramal says it will snatch up university CDMO for its injectables...

India's Piramal Enterprises said it was on the cusp of buying a CDMO founded at the University of Kentucky. That comes weeks after Japan's Fujifilm Diosynth Biotechnologies bought half of a vaccine...

View Article

New Jersey company investing up to $1M in plant, now offers contract...

Enteris BioPharma, which was formed in August 2013, will offer contract manufacturing after investing about $1 million into its 32,000-square-foot, FDA-approved manufacturing plant where it makes...

View Article

Norway's Weifa bets growth on separate API biz

Norwegian drugmaker Weifa figures its consumer health biz and its contract active pharmaceutical ingredient operations both have a better shot at growth if they go their separate ways. To make that...

View Article

Manufacturers' association says pharma contract manufacturing in India...

The Indian Drug Manufacturers' Association says the country's pharmaceutical contract manufacturing industry is growing at 20%.read more

View Article


AMRI's revenues soar 45% as refocus on contract manufacturing pays off

AMRI, having refocused on its contract manufacturing operations, saw the changes pay off last year, according to its recently released earnings. The Albany, NY-based CDMO reported that revenue grew 45%...

View Article

Boehringer Ingelheim wins first client for China biologics plan

While other drugmakers were building plants in China to make their own medications, Germany's Boehringer Ingelheim saw an opportunity to build one to cater to Chinese companies working on cell-based...

View Article

Browsing latest articles
Browse All 41 View Live




Latest Images